Author

Chhaya Maurya

University of California, Irvine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Lbachir BenMohamediD· 2 shared Swayam PrakashiD· 2 shared Sweta KaraniD· 2 shared Aziz Alami ChentoufiiD· 1 shared Junseong Hwang· 1 shared Khan Intharachalit· 1 shared Sarah Xue Le NgiD· 1 shared Sarah Xue LeNg· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Lbachir BenMohamedORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Tissue-Targeted Immunotherapy Protects Against Recurrent Ocular Herpes Infection and Disease, and Alleviates the Associated Cognitive, Behavioral, and Social Deficits in a 'Humanized' HLA Transgenic Mouse Model of UVB-Induced Reactivation

Sweta Karan, Swayam Prakash, Aziz Alami Chentoufi, Khan Intharachalit, Sarah Xue Le Ng, Junseong Hwang, Chhaya Maurya, Lbachir BenMohamed

This paper demonstrates that a PPK immunotherapy reduces HSV-1 reactivation and associated neurobehavioral deficits in a humanized mouse model.

bioRxiv · Oct 2, 2026 · PreprintImmunology

Tissue-Resident and Effector-Memory Lymphocyte Recruitment to the Ocular Mucosa Requires CCL28/CCR10 Signaling During Recurrent HSV-1 Infection

Sweta Karan, Swayam Prakash, Chhaya Maurya, Sarah Xue LeNg, Lbachir BenMohamed

This study shows that CCL28/CCR10 signaling is essential for recruiting protective lymphocytes to the ocular mucosa during recurrent HSV-1 infection, reducing viral burden and ocular pathology.

bioRxiv · Sep 20, 2026 · PreprintImmunology